Back to Blogs

Fulvestrant 250 mg Injection Export from India: A Guide for International Pharmaceutical Buyers

Category: Medicine
  • Tags:
  • Fulvestrant Injection, Fulvestrant 250 mg, Breast Cancer Medicine, Oncology Medicines, Pharmaceutical Export India, Oncology Injection Supplier, Dolphin Pharmaceuticals
Blog post featured image

Fulvestrant 250 mg Injection

Fulvestrant 250 mg injection is a prescription oncology medicine used in the treatment of certain types of hormone receptor-positive breast cancer. For international pharmaceutical importers, distributors, hospitals, and authorized medicine procurement organizations, sourcing this product requires careful attention to product specifications, manufacturer information, storage conditions, documentation, and destination-country regulations.

India is an established pharmaceutical sourcing destination, offering international buyers access to a range of generic and specialty medicines. However, product availability and export eligibility must be confirmed for each requested medicine and destination market.

Dolphin Pharmaceuticals is an India-based pharmaceutical supplier and exporter that international buyers can contact regarding pharmaceutical sourcing requirements. Its published product catalogue includes Fulvestrant 250 mg injection listings.

What Is Fulvestrant 250 mg Injection?

Fulvestrant is an estrogen receptor antagonist used in the treatment of certain hormone receptor-positive advanced or metastatic breast cancers. It works by blocking and reducing estrogen receptor activity, helping limit the effects of estrogen on cancer cells in appropriate clinical settings.

Fulvestrant is administered by intramuscular injection by qualified healthcare professionals. Its use depends on the patient's diagnosis, clinical circumstances, and the treatment plan prescribed by the treating specialist.

This medicine is intended for prescription use and should be used only under appropriate medical supervision.

Fulvestrant 250 mg Injection: Product Details

  • Generic Name: Fulvestrant
  • Strength: 250 mg/5 mL (confirm the specific presentation)
  • Dosage Form: Injection
  • Therapeutic Category: Oncology Medicine
  • Primary Use: Certain hormone receptor-positive breast cancers
  • Route of Administration: Intramuscular injection
  • Storage: Follow the manufacturer's instructions; many presentations require refrigeration at 2°C–8°C and protection from light.
  • Availability: Confirm current availability with Dolphin Pharmaceuticals.

For International Buyers: Verify the manufacturer, packaging, product documentation, storage requirements, and destination-country import eligibility before placing an order.

Therapeutic Use of Fulvestrant Injection

Fulvestrant is used in selected treatment settings for hormone receptor-positive advanced breast cancer. Whether it is appropriate for a particular patient depends on clinical factors and the applicable treatment guidelines.

For pharmaceutical buyers, understanding the product's therapeutic category helps with procurement planning, but it does not replace clinical evaluation.

Buyers should confirm the exact product name, strength, dosage form, manufacturer, and intended market authorization when requesting a quotation.

Fulvestrant 250 mg Injection Export from India

International sourcing of Fulvestrant injection involves more than identifying a supplier. Buyers need to confirm the product's origin, availability, quality documentation, storage requirements, and regulatory eligibility for the destination country.

Before placing an order, international pharmaceutical buyers should verify:

  • Exact product name and strength.
  • Manufacturer and country of manufacture.
  • Packaging type and pack size.
  • Product availability and shelf life.
  • Applicable quality and batch documentation.
  • Refrigerated shipping requirements, where applicable.
  • Destination-country registration and import permissions.
  • Commercial terms and export documentation.

These checks help establish a clear procurement process and reduce the risk of documentation or shipping problems.

Dolphin Pharmaceuticals: Fulvestrant Injection Sourcing

Dolphin Pharmaceuticals' online product catalogue includes listings for Fulvestrant 250 mg injection, including presentations identified as Fulveser and Fulzos.

The published listings identify different manufacturers and packaging formats. Buyers should therefore verify the precise product they require rather than assuming that all presentations are interchangeable.

For an inquiry, buyers should request confirmation of:

  • Current product availability.
  • Actual manufacturer.
  • Strength and presentation.
  • Pack size and packaging details.
  • Product-specific quality documents.
  • Storage and transportation requirements.
  • Export eligibility for the intended destination.
  • Quotation and minimum order quantity.

Product listings may change, and a catalogue entry does not guarantee current stock or authorization in a particular country. All details should be confirmed directly before placing an order.

Quality Documentation and Product Verification

Quality documentation is an important part of oncology medicine procurement. International buyers should request documents relevant to the specific product and transaction.

Depending on the product and destination-market requirements, these may include:

  • Product specifications.
  • Manufacturer details.
  • Applicable manufacturing or quality certifications.
  • Batch number and expiry information.
  • Certificate of analysis, where applicable.
  • Product labeling and packaging information.
  • Storage and handling instructions.
  • Commercial and regulatory shipping documents.

Buyers should ensure that the documentation matches the exact product and manufacturer being offered.

Storage and Transportation Requirements

Fulvestrant injection commonly requires refrigerated storage at 2°C–8°C, with protection from light. Requirements should always be confirmed against the specific manufacturer's approved product information.

For international shipments, buyers and suppliers should coordinate appropriate packaging and temperature-controlled transportation where required.

Important considerations include:

  • Maintaining the required temperature range.
  • Protecting the product from light.
  • Checking shelf life at the expected delivery date.
  • Confirming temperature-monitoring arrangements where needed.
  • Reviewing procedures for shipping delays or temperature excursions.
  • Ensuring the product is handled according to manufacturer instructions.

Appropriate handling is essential to preserving the product's specified storage conditions throughout the supply chain.

Regulatory Considerations for International Buyers

Pharmaceutical import requirements differ by country. A medicine available in India is not automatically approved for importation or sale in every international market.

Before confirming a shipment, the importing organization should establish:

  1. Whether Fulvestrant injection is registered or otherwise authorized in the destination market.
  2. Which import permits or approvals are required.
  3. Whether the importing organization is authorized to import the product.
  4. Which product, quality, and commercial documents must accompany the shipment.
  5. Whether the packaging, labeling, and transportation arrangements meet local requirements.

The exporter and importer should clarify their responsibilities before the order is finalized.

How to Request a Fulvestrant Injection Quotation

To help a supplier assess an inquiry, international buyers should provide:

  • Required product name.
  • Strength and presentation.
  • Preferred manufacturer, if applicable.
  • Required quantity.
  • Destination country.
  • Importer or organization details.
  • Documentation requirements.
  • Expected delivery timeframe.
  • Any specific storage or shipping requirements.

The supplier can then confirm whether a suitable product is available and provide relevant commercial and product information for review.

Frequently Asked Questions

What is Fulvestrant 250 mg injection used for?

Fulvestrant is used to treat certain hormone receptor-positive advanced or metastatic breast cancers. Treatment suitability must be determined by a qualified healthcare professional.

Is Fulvestrant 250 mg injection available from India?

Product availability depends on the supplier, manufacturer, and specific presentation. Buyers should confirm current availability directly with the supplier.

Does Dolphin Pharmaceuticals list Fulvestrant injection?

Its published catalogue includes Fulvestrant 250 mg injection listings. Current availability, manufacturer, documentation, and export eligibility should be confirmed before ordering.

How should Fulvestrant injection be stored?

Many presentations require refrigeration at 2°C–8°C and protection from light. Buyers must follow the storage instructions supplied with the specific product.

What should international buyers verify before importing?

Buyers should confirm the actual manufacturer, product specifications, relevant quality documents, destination-market authorization, import requirements, and shipping conditions.

Conclusion

Fulvestrant 250 mg injection is an oncology medicine used in the treatment of certain hormone receptor-positive breast cancers. International pharmaceutical buyers sourcing this medicine from India should carefully evaluate product specifications, manufacturer information, quality documentation, storage requirements, and destination-country regulations.

Dolphin Pharmaceuticals can be contacted to discuss Fulvestrant injection sourcing requirements. Product availability, packaging, manufacturer, documentation, and export eligibility should be confirmed individually before an order is placed.

For authorized pharmaceutical importers and distributors, responsible procurement begins with accurate product verification, regulatory compliance, and appropriate handling throughout the supply chain.

My Company Name - Dolphin Pharmaceuticals

My Website - https://www.dolphinpharma.in/